Searched for
ACTAVIS OPERATIONS
Lupin appoints Dr Ranjana Pathak as chief quality officerDr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla...- Intas closing in on Mallinckrodt’s US generics businessThis comes as US President Donald Trump has declared opioid addiction a public health emergency in the US and drugmakers have found themsel...
- Aurobindo Pharma to buy Portugal's Generis for 135 mn euroAurobindo Pharma has inked an agreement through its subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica.
- Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players clubWith the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...
- Buy Aurobindo Pharma, target Rs 1050: BofA-MLSustained operational momentum was largely in line with our and consensus estimates. The US biz growth on new launches in the oral and inje...
- Israel's Teva buys Allergan generic drug company for $40.5 billionTeva Pharmaceutical Industries Ltd. says it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion.
- Aurobindo Pharma posts net profit of Rs 393.40 crore in Q1Aurobindo Pharma today reported a consolidated net profit of Rs 393.40 cr in the first quarter ended June 30, 2014 on good performance of U...
- Aurobindo Pharma eyes $2 billion revenues in FY15The consolidated revenue (net) from operations was higher over the previous year by 38.3 per cent at nearly Rs 8,100 crore during 2013-14.
- Aurobindo shares up nearly 5% on boursesShares of Aurobindo Pharma today climbed nearly 5% after the co completed acquisition of certain commercial operations of Actavis Plc in We...
- Aurobindo Pharma hits fresh 52-week high on acquisition of select Actavis opsThe stock has rallied nearly 40 per cent so far in the year 2014.
- Aurobindo completes acquisition of select Actavis operationsAurobindo Pharma today said it has completed acquisition of certain commercial operations of Actavis Plc in Western Europe.
- Dealing room: Aurobindo Pharma, TVS Motors, Nucleus SoftwareET Now spoke to dealers on institutional and high net worth investors’ activity in the dealing room. The following stocks are on their rada...
- Aurobindo Pharma rallies nearly 7% on Actavis acquisition plansAurobindo Pharma rallied as much as 6.8 per cent, after the generics drug maker signed a binding offer agreement to acquire Actavis.
- Aurobindo Pharma to acquire Activis' operations in 7 European nationsAurobindo expects to acquire personnel, commercial infrastructure, products, marketing authorisations and dossier licence rights in seven E...
- Regenix beefs Board, goes for out-of-court settlement with StridesRegenix promoter Dr A Ramamurthy made waves in the pharma circuit in 2007. That was when the physician-entrepreneur sold the marketing righ...
- Cipla, PEs team up for Merck's bizRanbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
- Merck Generics valuation to be hit as Duoneb patent endsMerck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...
- Actavis acquires Sanmar subsidiaryActavis Group, the global generic pharma company, has announced the acquisition of the Active Pharmaceutical Ingredient (API).
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Actavis acquires Grandix manufacturing plantActavis Group, an international generic pharmaceuticals company has acquired the three-year-old manufacturing factory of Chennai-based Gran...
Load More
